To understand protective immune responses against the onset of group A Streptococcus respiratory infection, we investigated whether MyD88 KO mice were susceptible to acute infection through transmission. After commingling with mice that had intranasal group A Streptococcus (GAS) inoculation, MyD88 recipient mice had increased GAS loads in the nasal cavity and throat that reached a mean throat colonization of 6.3 × 10 CFU/swab and mean GAS load of 5.
View Article and Find Full Text PDFGroup A (GAS) commonly causes pharyngitis and skin infections. Little is known why streptococcal pharyngitis usually does not lead to pneumonia and why the skin is a favorite niche for GAS. To partially address these questions, the effectiveness of neutrophils in clearing wild-type (wt) M1T1 GAS strain MGAS2221 from the lung and from the skin was examined in murine models of intratracheal pneumonia and subcutaneous infection.
View Article and Find Full Text PDFNatural mutations of the two-component regulatory system CovRS are frequently associated with invasive group A (GAS) isolates and lead to the enhancement of virulence gene expression, innate immune evasion, systemic dissemination, and virulence. How CovRS mutations enhance systemic dissemination is not well understood. A hypervirulent GAS isolate of the 3 genotype, MGAS315, was characterized using a mouse model of pulmonary infection to understand systemic dissemination.
View Article and Find Full Text PDFHypervirulent group A streptococcus (GAS) can inhibit neutrophil recruitment and cause systemic infection in a mouse model of skin infection. The purpose of this study was to determine whether platelet-activating factor acetylhydrolase Sse and streptolysin S (SLS) have synergistic contributions to inhibition of neutrophil recruitment and systemic infection in subcutaneous infection of mice by MGAS315, a hypervirulent genotype GAS strain. Deletion of and in MGAS315 synergistically reduced the skin lesion size and GAS burden in the liver and spleen.
View Article and Find Full Text PDFGroup A Streptococcus (GAS) acquires mutations of the virulence regulator CovRS in human and mouse infections, and these mutations result in the upregulation of virulence genes and the downregulation of the protease SpeB. To identify in vivo mutants with novel phenotypes, GAS isolates from infected mice were screened by enzymatic assays for SpeB and the platelet-activating factor acetylhydrolase Sse, and a new type of variant that had enhanced Sse expression and normal levels of SpeB production was identified (the variants had a phenotype referred to as enhanced Sse activity [Sse] and normal SpeB activity [SpeB]). Sse SpeB variants had transcript levels of CovRS-controlled virulence genes comparable to those of a covS mutant but had no covRS mutations.
View Article and Find Full Text PDF